We are committed to providing access to the latest, most effective treatments for leukemias. All patients are offered the best conventional therapies; eligible patients are also given the opportunity to participate in clinical trials that evaluate promising new therapies—often years before they become widely available to all patients. Recent examples are:

• use of cord blood transplantation
• mismatched family member (haploidentical) stem cell transplantation for patients who do not have a family donor.
• stem cell biology and how blood cells are made
• new drug therapies for acute leukemia
• new treatment options for patients with relapsed leukemia
• strategies to decrease side effects from stem cell transplants

Physicians provide patients with information about clinical trials that may be appropriate and help guide them through the process of decision-making and enrollment.